New York State Common Retirement Fund
SPRO icon

New York State Common Retirement Fund’s Spero Therapeutics SPRO Stock Holding History

New York State Common Retirement Fund’s Portfolio SPRO Stock Details SPRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-223
Closed – – 3432
2022
Q2 		$0 Sell
223
-16,900
-99% -$49.1K ﹤0.01% 3536
2022
Q1 		$149K Sell
17,123
-36,605
-68% -$375K ﹤0.01% 2919
2021
Q4 		$860K Sell
53,728
-17,492
-25% -$278K ﹤0.01% 2164
2021
Q3 		$1.31M Buy
71,220
+21,329
+43% +$342K ﹤0.01% 1994
2021
Q2 		$696K Sell
49,891
-8,638
-15% -$121K ﹤0.01% 2402
2021
Q1 		$862K Hold
58,529
– – ﹤0.01% 2185
2020
Q4 		$1.14M Buy
58,529
+13,200
+29% +$206K ﹤0.01% 1986
2020
Q3 		$506K Buy
45,329
+18,600
+70% +$220K ﹤0.01% 2206
2020
Q2 		$362K Buy
26,729
+8,300
+45% +$93.2K ﹤0.01% 2378
2020
Q1 		$149K Buy
18,429
+1,879
+11% +$16.6K ﹤0.01% 2602
2019
Q4 		$159K Hold
16,550
– – ﹤0.01% 2835
2019
Q3 		$175K Buy
16,550
+2,522
+18% +$26.6K ﹤0.01% 2834
2019
Q2 		$161K Sell
14,028
-622
-4% -$7.49K ﹤0.01% 2929
2019
Q1 		$188K Sell
14,650
-1,050
-7% -$11.1K ﹤0.01% 2745
2018
Q4 		$97K Sell
15,700
-450
-3% -$3.64K ﹤0.01% 2972
2018
Q3 		$170K Hold
16,150
– – ﹤0.01% 2900
2018
Q2 		$237K Buy
+16,150
New +$207K ﹤0.01% 2795

Other funds holding SPRO

ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
AVAI
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return

New York State Common Retirement Fund's SPRO Position: Q3 2022 in Review

New York State Common Retirement Fund sold out of Spero Therapeutics (SPRO) in Q3 2022, closing a stake of 223 shares.

New York State Common Retirement Fund first reported a position in SPRO in Q2 2018 and held it in 17 quarters. The position peaked at $1.31M in Q3 2021. 69 funds tracked by Wall St. Rank hold SPRO as of Q3 2022.

  • New York State Common Retirement Fund reported no remaining Spero Therapeutics position as of Q3 2022 after selling out during the quarter.
  • New York State Common Retirement Fund sold 223 Spero Therapeutics shares in Q3 2022.
  • New York State Common Retirement Fund first reported a position in Spero Therapeutics in Q2 2018 and held it in 17 quarters.
  • New York State Common Retirement Fund's Spero Therapeutics position peaked at $1.31M in Q3 2021.
  • 69 funds tracked by Wall St. Rank held Spero Therapeutics as of Q3 2022.

Based on New York State Common Retirement Fund's 13F filing for Q3 2022, filed 8 Nov 2022.